Chemic Laboratories Inc.and Arihant Innochem Pvt. Ltd India Announce Joint Cooper

CANTON, Mass. - Jan. 3, 2019 - PRLog -- Chemic Laboratories Inc., a global leader in the contract analytical space supporting pharmaceutical development, and Arihant Innochem Pvt. Ltd, an  importer & distributor of high-quality specialty chemicals, today announced the establishment of a formal one year renewable Joint Cooperation Agreement. This agreement will enable the two firms to collaborate on a variety of Pharmaceutical and Medical Device client interests, primarily in the areas of product development as it pertains to excipient and drug substance materials analysis and container closure assessment in the area of extractables and leachables testing. Under this agreement, the companies can now leverage their collective expertise in analytics, development, consulting and commercial manufacturing to make an important difference in their client's business performance.

"Chemic is very excited to move forward with this formal working relationship with ARIHANT. ARIHANT is an important leader in the Asia Pacific territories and with Chemic's assistance will be able to further support their customers' needs when developing products for the US, European, and Asian market" said Joseph St. Laurent, President and CSO of Chemic Laboratories Inc.

Bhadresh Shah DCM of stated "Arihant Innochem Pvt. Ltd, a leading distributor of specialty excipients in India and neighboring countries is proud to partner with Chemic Laboratories, USA and bring their valuable services to the markets we cater. This is a big leap for Arihant in the direction of value added services for our customers, which is our vision and future focus. The partnership brings to Chemic dedicated regional technical expertise and a strong network of customer base to promote their services. We are very enthusiastic about this alliance and hope this synergy will be fruitful to both companies."

The cooperation model between the two companies will consist of ARIHANT identifying and consulting with pharmaceutical and biopharmaceutical customers while Chemic will utilize well established and developed analytics to provide services to allow the Sponsor companies to more efficiently enter the US, European, and Asian regulatory drug development market place. (http://chemiclabs.com)